Drug Shortage Report for APO-BRIMONIDINE

Last updated on 2018-07-17 History
Report ID 50041
Drug Identification Number 02260077
Brand name APO-BRIMONIDINE
Common or Proper name BRIMONIDINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) BRIMONIDINE TARTRATE
Strength(s) 0.2%
Dosage form(s) SOLUTION
Route of administration OPHTHALMIC
Packaging size 5 ML & 10 ML
ATC code S01EA
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-05-21
Estimated end date 2018-07-16
Actual end date 2018-07-16
Shortage status Resolved
Updated date 2018-07-17
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-07-17 French Compare
v3 2018-07-17 English Compare
v2 2018-05-22 French Compare
v1 2018-05-22 English Compare